Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Plug to Participate in the Canaccord Growth Conference
-
TeraWulf Reschedules Second Quarter 2025 Investor Conference Call to Thursday, August 14, 2025
-
PDS Biotech Reports Second Quarter 2025 Financial Results and Provides Clinical Programs Update
-
ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights
-
Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)
-
ARS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy® (epinephrine nasal spray)
-
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
-
Form 8.3 - Empiric Student Property Plc
-
Form 8.5 (EPT/RI) - H&T Group Plc
-
Immatics Announces Second Quarter 2025 Financial Results and Business Update
-
Blubird Launches $BLU Token to Power the Future of Real-World Asset Tokenization
-
Rego Payment Architectures, Inc. and Aambé Financial Announce Partnership to Expand Financial Inclusion Across Indian Country
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
YieldMax® ETFs Announces Distributions on PLTY, ULTY, MARO, LFGY, MRNY and Others
-
Form 8.5 (EPT/RI) - Epwin Group Plc
-
Correction: Form 8.3 - Tritax Big Box Reit Plc
-
Endeavour Silver Announces Q2 2025 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today
-
RentRedi Makes 2025 Inc. 5000 List for Second Consecutive Year
-
Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results
-
Gildan and HanesBrands Agree to Combine To Create a Global Basic Apparel Leader
-
K92 Mining Strengthens Community Affairs and External Relations Leadership with Key Appointments
-
BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates
-
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease
-
Intention to utilise an over allotment facility
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UNITE GROUP PLC/THE - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TRITAX BIG BOX REIT PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RICARDO PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - EMPIRIC STUDENT PROPERTY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DUNDEE PRECIOUS METALS INC - Ordinary Shares
-
Hudbay Delivers Strong Second Quarter 2025 Results
-
Global-e Reports Second Quarter 2025 Results
-
Hudbay Announces $600 Million Strategic Investment from Mitsubishi Corporation for 30% Joint Venture Interest in Copper World
-
Osisko Metals Intersects 731 Metres Averaging 0.29% Cu at Gaspé
-
Katapult Delivers Second Quarter Gross Originations, Revenue and Adjusted EBITDA Above Outlook
-
ExGen Resources and MTB Metals Enter into Non-Binding Letter of Intent to Merge, Creating a Copper, Gold and Lithium Exploration and Development Company
-
Canadian Credit Market Shows Signs of Recovery as New Mortgages Rise 51% Year-Over-Year
-
Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceutical
-
Tower Semiconductor Launches 2025 Technical Global Symposium Series
-
Yuanbao Inc. to Announce Second Quarter 2025 Financial Results on Wednesday, August 27, 2025
-
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
-
First Atlantic Nickel Reports Initial Phase 2 Drill Results: Deepest Drill Hole to Date at RPM Zone Returns 1.27% Awaruite Nickel Alloy (Ni₃Fe) in Magnetic Concentrate Over 447 Meters
-
Instil Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Zeo Energy Corp. Reports Second Quarter 2025 Financial Results
-
Goranson Bain Ausley Named #1 Family Law Firm in Austin/San Antonio and Dallas/Fort Worth for Third Consecutive Year
-
European Wax Center, Inc. Reports Second Quarter Fiscal Year 2025 Results
-
Neuronascent Announces Progress for Lead Candidate NNI-362: Publication of Phase 1a Clinical Trial Results and FDA Grants Waiver of Fee for Canine Cognitive Disorder 2025 Submissions
-
AirSculpt Technologies Announces Participation in Sidoti Micro Cap Conference
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
WEBTOON Entertainment Inc. to Participate in Upcoming Investor Conferences
-
AXIL Brands, Inc. Announces Major National Retail Partnership

